Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Global Liver Cancer Therapeutics Market, By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Liver Metastasis, Hepatoblastoma, Angiosarcoma), By Therapy (Targeted Therapy, Radiation and Chemotherapy Therapy, Immunotherapy, Others), By Equipment (Computed Radiography, MRI, Sonography, Others), By Age (0-18, 18-35, 35-50, 50+), By Factors (Non-Alcoholic Fatty Liver Disease, Cirrhosis, Excessive Liver Consumption, Others), By Route of Administration (Oral, Intra-Venous, Others ), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2025
Global liver cancer therapeutics market is forecast to grow in the coming years and reach $ 11 billion by 2025. Major factors behind the growth of this market include rising cases of liver cancer, glo...
2024 POC Hemostasis Diagnostics Market: Supplier Shares and Sales Segment Forecasts-Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
This new 418-page report from LeadingMarketResearch contains 42 tables, and provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulator...
2024 World Hemostasis Diagnostics Market: Supplier Shares by Country, Emerging Tests, Technology Trends, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers
This new 302-page report from LeadingMarketResearch provides an analysis of the global coagulation testing market, including emerging tests, technologies, instrumentation, sales forecasts by country,...
2024 Global Nucleic Acid Testing/NAT Market: Supplier Shares by Country, Facilities, Test Volumes, and Sales Forecasts by Country
This report provides:Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA.Estimates of facilities performing DNA sequencing and molecular...
2024 POC Clinical Chemistry and Immunodiagnostic Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
... the patient. Market Segmentation Review of the POC clinical chemistry and immunodiagnostic market segments, including their dynamics, trends, ... clinical chemistry procedures by market segment: Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care ...